SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 245 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $1,356,000 | -26.5% | 11,800 | 0.0% | 0.15% | -42.4% |
| Q3 2014 | $1,844,000 | -31.4% | 11,800 | -45.9% | 0.26% | -29.8% |
| Q2 2014 | $2,689,000 | +26.6% | 21,800 | +6.3% | 0.37% | +10.9% |
| Q1 2014 | $2,124,000 | +162.5% | 20,500 | +127.8% | 0.33% | +32.5% |
| Q4 2013 | $809,000 | – | 9,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 467,943 | $30,954,000 | 11.01% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $19,845,000 | 7.82% |
| OAK RIDGE INVESTMENTS LLC | 1,382,895 | $91,478,000 | 2.87% |
| SECTOR GAMMA AS | 147,001 | $9,724,000 | 2.84% |
| Credo Capital Management, LLC | 38,869 | $2,571,000 | 1.98% |
| Cardinal Capital Management | 48,226 | $3,190,000 | 1.89% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 626,800 | $41,463,000 | 1.68% |
| HERNDON CAPITAL MANAGEMENT LLC | 1,284,472 | $84,967,823,000 | 1.27% |
| CATAPULT CAPITAL MANAGEMENT LLC | 45,000 | $2,977,000 | 1.24% |
| Pier Capital, LLC | 108,556 | $7,181,000 | 1.10% |